Lv7
4990 积分 2021-10-16 加入
The nucleosome assembly protein 1 like 1: From histone chaperone to disease regulator
18天前
已完结
Discovery of ART0380, a Potent and Selective ATR Kinase Inhibitor Undergoing Phase 2 Clinical Studies for the Treatment of Advanced or Metastatic Solid Cancers
25天前
已完结
Recent advances in small molecule ATR kinase inhibitors as anticancer agents
25天前
已完结
Discovery and Characterization of (8S,9R)-5-Fluoro-8-(4-fluorophenyl)-9-(1-methyl-1H-1,2,4-triazol-5-yl)-2,7,8,9-tetrahydro-3H-pyrido[4,3,2-de]phthalazin-3-one (BMN 673, Talazoparib), a Novel, Highly Potent, and Orally Efficacious Poly(ADP-ribose) Polymerase-1/2 Inhibitor, as an Anticancer Agent
1个月前
已完结
Introducing Cysteines into Nanobodies for Site-Specific Labeling
1个月前
已完结
Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging
1个月前
已完结
A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase
1个月前
已完结
Identification of a murine CD28 dileucine motif that suppresses single-chain chimeric T-cell receptor expression and function
2个月前
已完结
Discovery of selective PARP1/CDK6 dual target inhibitors modulating Wnt signaling pathway for the treatment of TNBC
2个月前
已完结
Synergy trap for guardian angels of DNA: Unraveling the anticancer potential of phthalazinone-thiosemicarbazone hybrids through dual PARP-1 and TOPO-I inhibition
2个月前
已完结
皖公网安备34019202002308
